VVT Med Inc. (TSXV:VVTM)

Market Cap	14.56M -29.7%
Revenue (ttm)	136.33K -83.2%
Net Income	-5.83M
EPS	-0.07
Shares Out	76.61M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,000
Open	0.1750
Previous Close	0.1900
Day's Range	0.1500 - 0.1900
52-Week Range	0.1500 - 0.4500
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About VVT Med

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VVTM

Financial Performance

In 2025, VVT Med's revenue was $89,000, a decrease of -81.91% compared to the previous year's $492,000. Losses were -$3.98 million, 282.3% more than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 4, 2026

Data Sources Report a data error